Joshua Bauml, MD, assistant professor, Perelman School of Medicine, University of Pennsylvania, discusses the use of locally ablative therapy in patients with oligometastatic non–small cell lung cancer.
- Dr. Bauml on Locally Ablative Therapy in Oligometastatic NSCLC ( Download)
- Dr. Bauml on the Use of Immunotherapy in Oligometastatic NSCLC ( Download)
- Dr. Bauml on Treatment For Oligometastatic NSCLC ( Download)
- Pembrolizumab as Treatment for Oligometastatic NSCLC ( Download)
- Managing Oligometastases With Ablative Therapy in NSCLC ( Download)
- Dr. Mix on Local Consolidative Therapy in Oligometastatic NSCLC ( Download)
- Radical treatment for oligometastatic NSCLC ( Download)
- Dr. Bauml on Emerging Biomarkers in NSCLC ( Download)
- GRACEcast - Emerging Molecular Targets in NSCLC- MET with Dr. Josh Bauml ( Download)
- Dr. Choy Discusses Therapy for Oligometastatic Lung Cancer ( Download)
- GRACEcast - Emerging Molecular Targets in NSCLC- RET Fusions with Dr. Josh Bauml ( Download)
- Lung Cancer Video Library 2020 - BAUML - Emerging Molecular Targets in NSCLC MET ( Download)
- Dr. Bauml on a New Platform to Enhance Lung Cancer Clinical Trial Enrollment ( Download)
- World Cancer Day with Dr. Bauml ( Download)
- Dr. Urbanic on the Role of Radiotherapy in Oligometastatic NSCLC ( Download)